
Jonathan Block
Managing Editor, Sectors at Seeking Alpha
Managing Editor, Sectors and Senior Health Care News Editor at Seeking Alpha. MPH from CUNY Graduate School of Public Health. All opinions are mine.
Articles
-
1 day ago |
seekingalpha.com | Jonathan Block
U.S. stock index futures are considerably higher early Tuesday evening after President Donald Trump said he has "no intention" of firing Federal Reserve. "I would like to see him be a little more active in terms of his idea to
-
2 days ago |
seekingalpha.com | Jonathan Block
REMX--VanEck Rare Earth and Strategic Metals ETFITA--iShares U.S. Aerospace & Defense ETFXAR--SPDR® S&P Aerospace & Defense ETFDFEN--Direxion Daily Aerospace & Defense Bull 3X Shares Direxion Daily Aerospace ETF
-
2 days ago |
seekingalpha.com | Jonathan Block
ozgurdonmaz/iStock via Getty Images The U.S. FDA has issued a warning to consumers, health care professionals, and compounders over potential dangers associated with compounded versions of the drug finasteride in topical form, which is used as a male pattern baldness treatment. The agency noted
-
2 days ago |
seekingalpha.com | Jonathan Block
-
2 days ago |
seekingalpha.com | Jonathan Block
Although UnitedHealth Group (NYSE:UNH) spent over $1.6M for security for several of its top executives in 2024, Brian Thompson, the CEO of its health benefits unit who was gunned down in front of a Manhattan hotel in December
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 449
- Tweets
- 872
- DMs Open
- No

Yet another interesting development involving @CassavaSciences #Alzheimers #CUNY Interesting that $SAVA shares up 12% in Tuesday afternoon trading. https://t.co/cHMREionxh

Exciting news for @GEHealthCare and @VUMCDiscoveries, and promising for using #ai to improve health outcomes for #cancer patients. https://t.co/3necZyZqtn

Antibody-drug conjugates, a relatively new type of cancer treatment, are poised to boost the bottom lines on several pharma and biotech companies. https://t.co/BQPaw7U4Ny